Effect of neuromedin U on allergic airway inflammation in an asthma model (Review)
- Authors:
- Xiaojie Ren
- Fang Dong
- Yuerong Zhuang
- Yong Wang
- Wuhua Ma
-
Affiliations: Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510405, P.R. China - Published online on: December 4, 2019 https://doi.org/10.3892/etm.2019.8283
- Pages: 809-816
-
Copyright: © Ren et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al: After asthma: Redefining airways diseases. Lancet. 391:350–400. 2018. View Article : Google Scholar : PubMed/NCBI | |
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 31:143–178. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ray A, Raundhal M, Oriss TB, Ray P and Wenzel SE: Current concepts of severe asthma. J Clin Invest. 126:2394–2403. 2016. View Article : Google Scholar : PubMed/NCBI | |
Word Health Organiztion (2017), . Asthma Fact Sheet. http://www.who.int/mediacentre/factsheets/fs307/en/May 26–2018 | |
McInnes RN, Hernming D, Burgess P, Lyndsay D, Osborne NJ, Skjøth CA, Thomas S and Vardoulakis S: Mapping allergenic pollen vegetation in UK to study environmental exposure and human health. Sci Total Environ. 599-600:483–499. 2017. View Article : Google Scholar : PubMed/NCBI | |
Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, Ledford JG, dos Santos MM, Anderson RL, Metwali N, et al: Innate immunity and asthma risk in amish and hutterite farm children. N Engl J Med. 375:411–421. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, et al: Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): A randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 388:2115–2127. 2016. View Article : Google Scholar : PubMed/NCBI | |
Chiu CN, Rihel J, Lee DA, Singh C, Mosser EA, Chen SJ, Sapin V, Pham U, Engle J, Niles BJ, et al: A zebrafish genetic screen identifies neuromedin U as a regulator of sleep/wake states. Neuron. 89:842–856. 2016. View Article : Google Scholar : PubMed/NCBI | |
Schlegel P, Texada MJ, Miroschnikow A, Schoofs A, Hückesfeld S, Peters M, Schneider-Mizell CM, Lacin H, Li F, Fetter RD, et al: Synaptic transmission parallels neuromodulation in a central food-intake circuit. Elife. 5:e167992016. View Article : Google Scholar : PubMed/NCBI | |
Martinez VG and O'Driscoll L: Neuromedin U: A multifunctional neuropeptide with pleiotropic roles. Clin Chem. 61:471–482. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lee J, Snyder ER, Liu YH, Gu XY, Wang J, Flowers BM, Kim YJ, Park S, Szot GL, Hruban RH, et al: Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells. Nat Commun. 8:146862017. View Article : Google Scholar : PubMed/NCBI | |
Alfa RW, Park S, Skelly KR, Poffenberger G, Jain N, Gu X, Kockel L, Wang J, Liu YH, Powers AC and Kim SK: Suppression of insulin production and secretion by a decretin hormone. Cell Metab. 21:323–333. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour RE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D, et al: The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 549:351–356. 2017. View Article : Google Scholar : PubMed/NCBI | |
Cardoso V, Chesné J, Ribeiro H, García-Cassani B, Carvalho T, Bouchery T, Shah K, Barbosa-Morais NL, Harris N and Veiga-Fernandes H: Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature. 549:277–281. 2017. View Article : Google Scholar : PubMed/NCBI | |
Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar AL, Kabata H, Monticelli LA, Moriyama S, Putzel GG, Rakhilin N, et al: The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature. 549:282–286. 2017. View Article : Google Scholar : PubMed/NCBI | |
Hargreave FE and Nair P: The definition and diagnosis of asthma. Clin Exp Allergy. 39:1652–1658. 2009. View Article : Google Scholar : PubMed/NCBI | |
O'Reilly R, Ullmann N, Irving S, Bossley CJ, Sonnappa S, Zhu J, Oates T, Banya W, Jeffery PK, Bush A and Saglani S: Increased airway smooth muscle in preschool wheezers who have asthma at school age. J Allergy Clin Immunol. 131:1024–1032, 32.e1-16. 2013. View Article : Google Scholar : PubMed/NCBI | |
Noble PB, Pascoe CD, Lan B, Ito S, Kistemaker LE, Tatler AL, Pera T, Brook BS, Gosens R and West AR: Airway smooth muscle in asthma: Linking contraction and mechanotransduction to disease pathogenesis and remodelling. Pulm Pharmacol Ther. 29:96–107. 2014. View Article : Google Scholar : PubMed/NCBI | |
Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet LP and O'Byrne PM: Airway hyperresponsiveness in asthma: Measurement and clinical relevance. J Allergy Clin Immunol Pract. 5:649–659.e2. 2017. View Article : Google Scholar : PubMed/NCBI | |
Jackson DJ and Johnston SL: The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 125:1178–1187; quiz 1188–1189. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pascoe S, Locantore N, Dransfield MT, Barnes NC and Pavord ID: Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 3:435–442. 2015. View Article : Google Scholar : PubMed/NCBI | |
Brusselle GG, Maes T and Bracke KR: Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma. Nat Med. 19:977–979. 2013. View Article : Google Scholar : PubMed/NCBI | |
Veres TZ, Shevchenko M, Krasteva G, Spies E, Prenzler F, Rochlitzer S, Tschernig T, Krug N, Kummer W and Braun A: Dendritic cell-nerve clusters are sites of T cell proliferation in allergic airway inflammation. Am J Pathol. 174:808–817. 2009. View Article : Google Scholar : PubMed/NCBI | |
Furuhashi K, Chua YL, Wong KHS, Zhou Q, Lee DCP, Liong KH, Teo GH, Hutchinson PE and Kemeny DM: Priming with high and low respiratory allergen dose induces differential CD4+ T helper type 2 cells and IgE/IgG1 antibody responses in mice. Immunology. 151:227–238. 2017. View Article : Google Scholar : PubMed/NCBI | |
Suzuki R, Leach S, Liu WH, Ralston E, Scheffel J, Zhang W, Lowell CA and Rivera J: Molecular editing of cellular responses by the high-affinity receptor for IgE. Science. 343:1021–1025. 2014. View Article : Google Scholar : PubMed/NCBI | |
Cao PP, Zhang YN, Liao B, Ma J, Wang BF, Wang H, Zeng M, Liu WH, Schleimer RP and Liu Z: Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps. Clin Exp Allergy. 44:690–700. 2014. View Article : Google Scholar : PubMed/NCBI | |
Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, et al: A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nat Commun. 8:140172017. View Article : Google Scholar : PubMed/NCBI | |
Serafini N, Vosshenrich CA and Di Santo JP: Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol. 15:415–428. 2015. View Article : Google Scholar : PubMed/NCBI | |
Licona-Limón P, Kim LK, Palm NW and Flavell RA: TH2, allergy and group 2 innate lymphoid cells. Nat Immunol. 14:536–542. 2013. View Article : Google Scholar : PubMed/NCBI | |
Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D, Janss T, Starkl P, Ramery E, Henket M, et al: Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest. 126:3279–3295. 2016. View Article : Google Scholar : PubMed/NCBI | |
Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P, et al: IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 17:636–645. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wenzel SE: Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med. 18:716–725. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sugita K, Steer CA, Martinez-Gonzalez I, Altunbulakli C, Morita H, Castro-Giner F, Kubo T, Wawrzyniak P, Ruckert B, Sudo K, et al: Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 141:300–310.e11. 2018. View Article : Google Scholar : PubMed/NCBI | |
Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ and Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. formoterol and corticosteroids establishing therapy (FACET) international study group. N Engl J Med. 337:1405–1411. 1997. View Article : Google Scholar : PubMed/NCBI | |
Gibson PG, Powell H and Ducharme FM: Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol. 119:344–350. 2007. View Article : Google Scholar : PubMed/NCBI | |
Weinstein RS: Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 365:62–70. 2011. View Article : Google Scholar : PubMed/NCBI | |
Mak VH, Melchor R and Spiro SG: Easy bruising as a side-effect of inhaled corticosteroids. Eur Respir J. 5:1068–1074. 1992.PubMed/NCBI | |
Brown PH, Greening AP and Crompton GK: Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function. Thorax. 48:233–238. 1993. View Article : Google Scholar : PubMed/NCBI | |
Mukherjee M, Aleman Paramo F, Kjarsgaard M, Salter B, Nair G, LaVigne N, Radford K, Sehmi R and Nair P: Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab. Am J Respir Crit Care Med. 197:38–46. 2018. View Article : Google Scholar : PubMed/NCBI | |
Minamino N, Kangawa K and Matsuo H: Neuromedin U-8 and U-25: Novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun. 130:1078–1085. 1985. View Article : Google Scholar : PubMed/NCBI | |
Domin J, Ghatei MA, Chohan P and Bloom SR: Neuromedin U--a study of its distribution in the rat. Peptides. 8:779–784. 1987. View Article : Google Scholar : PubMed/NCBI | |
Tanida M, Satomi J, Shen J and Nagai K: Autonomic and cardiovascular effects of central neuromedin U in rats. Physiol Behav. 96:282–288. 2009. View Article : Google Scholar : PubMed/NCBI | |
Austin C, Lo G, Nandha KA, Meleagros L and Bloom SR: Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. J Mol Endocrinol. 14:157–169. 1995. View Article : Google Scholar : PubMed/NCBI | |
Gevaert B, Wynendaele E, Stalmans S, Bracke N, D'Hondt M, Smolders I, van Eeckhaut A and De Spiegeleer B: Blood-brain barrier transport kinetics of the neuromedin peptides NMU, NMN, NMB and NT. Neuropharmacology. 107:460–470. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mitchell JD, Maguire JJ and Davenport AP: Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol. 158:87–103. 2009. View Article : Google Scholar : PubMed/NCBI | |
Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GI, Murdock PR, Fitzgerald LR, Wu H, et al: Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem. 275:20247–20250. 2000. View Article : Google Scholar : PubMed/NCBI | |
Alexander SP, Mathie A and Peters JA: Guide to receptors and channels (GRAC), 3rd edition. Br J Pharmacol. 153 (Suppl 2):S1–S209. 2008. View Article : Google Scholar : PubMed/NCBI | |
Hosoya M, Moriya T, Kawamata Y, Ohkubo S, Fujii R, Matsui H, Shintani Y, Fukusumi S, Habata Y, Hinuma S, et al: Identification and functional characterization of a novel subtype of neuromedin U receptor. J Biol Chem. 275:29528–29532. 2000. View Article : Google Scholar : PubMed/NCBI | |
Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Habata Y, Hinuma S, Onda H, Nishimura O and Fujino M: Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem. 275:21068–21074. 2000. View Article : Google Scholar : PubMed/NCBI | |
Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DL Jr, Feighner SD, Nunes CN, et al: Identification of receptors for neuromedin U and its role in feeding. Nature. 406:70–74. 2000. View Article : Google Scholar : PubMed/NCBI | |
Kakarala KK and Jamil K: Sequence-structure based phylogeny of GPCR Class A Rhodopsin receptors. Mol Phylogenet Evol. 74:66–96. 2014. View Article : Google Scholar : PubMed/NCBI | |
Brighton PJ, Szekeres PG, Wise A and Willars GB: Signaling and ligand binding by recombinant neuromedin U receptors: Evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Mol Pharmacol. 66:1544–1556. 2004. View Article : Google Scholar : PubMed/NCBI | |
Hsu SH and Luo CW: Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs. Am J Physiol Endocrinol Metab. 293:E1021–E1029. 2007. View Article : Google Scholar : PubMed/NCBI | |
Moriyama M, Matsukawa A, Kudoh S, Takahashi T, Sato T, Kano T, Yoshimura A and Kojima M: The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. Biochem Biophys Res Commun. 341:1149–1154. 2006. View Article : Google Scholar : PubMed/NCBI | |
Johnson EN, Appelbaum ER, Carpenter DC, Cox RF, Disa J, Foley JJ, Ghosh SK, Naselsky DP, Pullen MA, Sarau HM, et al: Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1. J Immunol. 173:7230–7238. 2004. View Article : Google Scholar : PubMed/NCBI | |
Cording S, Medvedovic J, Aychek T and Eberl G: Innate lymphoid cells in defense, immunopathology and immunotherapy. Nat Immunol. 17:755–757. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang Y, Jiang D, Zhang Y, Jiang X, Wang F and Tao J: Neuromedin U type 1 receptor stimulation of A-type K+ current requires the βg subunits of Go protein, protein kinase A, and extracellular signal-regulated kinase 1/2 (ERK1/2) in sensory neurons. J Biol Chem. 287:18562–18572. 2012. View Article : Google Scholar : PubMed/NCBI | |
Gaudenzio N, Sibilano R, Marichal T, Starkl P, Reber LL, Cenac N, McNeil BD, Dong XZ, Hernandez JD, Sagi-Eisenberg R, et al: Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest. 126:3981–3998. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mizutani N, Nabe T and Yoshino S: IgE/antigen-mediated enhancement of IgE production is a mechanism underlying the exacerbation of airway inflammation and remodelling in mice. Immunology. 144:107–115. 2015. View Article : Google Scholar : PubMed/NCBI | |
Zhang N, Li H, Jia JH and He MQ: Anti-inflammatory effect of curcumin on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse. Cell Immunol. 298:88–95. 2015. View Article : Google Scholar : PubMed/NCBI | |
Tore F and Tuncel N: Mast cells: Target and source of neuropeptides. Curr Pharm Des. 15:3433–3445. 2009. View Article : Google Scholar : PubMed/NCBI | |
Moriyama M, Sato T, Inoue H, Fukuyama S, Teranishi H, Kangawa K, Kano T, Yoshimura A and Kojima M: The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med. 202:217–224. 2005. View Article : Google Scholar : PubMed/NCBI | |
Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O'Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin J, et al: Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol. 137:75–86.e8. 2016. View Article : Google Scholar : PubMed/NCBI | |
Mukherjee M, Bulir DC, Radford K, Kjarsgaard M, Huang CM, Jacobsen EA, Ochkur SI, Catuneanu A, Lamothe-Kipnes H, Mahony J, et al: Sputum autoantibodies in patients with severe eosinophilic asthma. J Allergy Clin Immunol. 141:1269–1279. 2018. View Article : Google Scholar : PubMed/NCBI | |
Johansson MW: Eosinophil activation status in separate compartments and association with asthma. Front Med (Lausanne). 4:752017. View Article : Google Scholar : PubMed/NCBI | |
Borchers MT, Justice PJ, Ansay T, Mancino V, McGarry MP, Crosby J, Simon MI, Lee NA and Lee JJ: Gq signaling is required for allergen-induced pulmonary eosinophilia. J Immunol. 168:3543–3549. 2002. View Article : Google Scholar : PubMed/NCBI | |
Moriyama M, Fukuyama S, Inoue H, Matsumoto T, Sato T, Tanaka K, Kinjyo I, Kano T, Yoshimura A and Kojima M: The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am J Physiol Lung Cell Mol Physiol. 290:L971–L977. 2006. View Article : Google Scholar : PubMed/NCBI | |
Talbot S, Foster SL and Woolf CJ: Neuroimmunity: Physiology and pathology. Annu Rev Immunol. 34:421–447. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ni D, Gu Q, Hu HZ, Gao N, Zhu MX and Lee LY: Thermal sensitivity of isolated vagal pulmonary sensory neurons: Role of transient receptor potential vanilloid receptors. Am J Physiol Regul Integr Comp Physiol. 291:R541–R550. 2006. View Article : Google Scholar : PubMed/NCBI | |
Myers AC, Kajekar R and Undem BJ: Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol. 282:L775–L781. 2002. View Article : Google Scholar : PubMed/NCBI | |
Canning BJ and Spina D: Sensory nerves and airway irritability. Handb Exp Pharmacol. 139–183. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, Xiao SY, Winston JH and Pasricha PJ: The proteinase-activated receptor 2 is involved in nociception. J Neurosci. 21:9036–9042. 2001. View Article : Google Scholar : PubMed/NCBI | |
Talbot S, Abdulnour RE, Burkett PR, Lee S, Cronin SJ, Pascal MA, Laedermann C, Foster SL, Tran JV, Lai N, et al: Silencing nociceptor neurons reduces allergic airway inflammation. Neuron. 87:341–354. 2015. View Article : Google Scholar : PubMed/NCBI | |
Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M, Hennessey R, Domin J, Bloom SR and Polak JM: Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience. 25:797–816. 1988. View Article : Google Scholar : PubMed/NCBI | |
Yu XH, Cao CQ, Mennicken F, Puma C, Dray A, O'Donnell D, Ahmad S and Perkins M: Pro-nociceptive effects of neuromedin U in rat. Neuroscience. 120:467–474. 2003. View Article : Google Scholar : PubMed/NCBI | |
Wall PD and Melzack R: Textbook of Pain. 4th. Churchill Livingstone; London: 1999 | |
Cao CQ, Yu XH, Dray A, Filosa A and Perkins MN: A pro-nociceptive role of neuromedin U in adult mice. Pain. 104:609–616. 2003. View Article : Google Scholar : PubMed/NCBI | |
Nakahara K, Kojima M, Hanada R, Egi Y, Ida T, Miyazato M, Kangawa K and Murakami N: Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice. Biochem Biophys Res Commun. 323:615–620. 2004. View Article : Google Scholar : PubMed/NCBI | |
Fang L, Zhang M, Li C, Dong S and Hu Y: Chemical genetic analysis reveals the effects of NMU2R on the expression of peptide hormones. Neurosci Lett. 404:148–153. 2006. View Article : Google Scholar : PubMed/NCBI | |
Zheng X, Hu Y, Liu J and Ouyang K: Screening of active compounds as neuromedin U2 receptor agonist from natural products. Bioorg Med Chem Lett. 15:4531–4535. 2005. View Article : Google Scholar : PubMed/NCBI | |
Takayama K, Mori K, Sohma Y, Taketa K, Taguchi A, Yakushiji F, Minamino N, Miyazato M, Kangawa K and Hayashi Y: Discovery of potent hexapeptide agonists to human neuromedin U receptor 1 and identification of their serum metabolites. ACS Med Chem Lett. 6:302–307. 2015. View Article : Google Scholar : PubMed/NCBI | |
Szczeklik A, Czerniawska-Mysik G, Adamek-Guzik T, Woloszynski J and Koterba A: Ketotifen versus sodium cromoglycate in the therapy of allergic (extrinsic) bronchial asthma. Respiration. 39 (Suppl 1):S3–S9. 1980. View Article : Google Scholar | |
Theiler A, Barnthaler T, Platzer W, Richtig G, Peinhaupt M, Rittchen S, Kargl J, Ulven T, Marsh LM, Marsche G, et al: Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival. J Allergy Clin Immunol. 144:764–776. 2019. View Article : Google Scholar : PubMed/NCBI |